Bessemer Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bessemer Group’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-160	Closed	-$2K	–	2780
2024 Q4	$2K	Hold	160	–	–	﹤0.01%	2291
2024 Q3	$2K	Buy	+160	New	+$1.61K	﹤0.01%	2304
2023 Q3	–	Sell	-1,056	Closed	-$15K	–	2367
2023 Q2	$15K	Buy	1,056 +76	+8%	+$1.29K	﹤0.01%	1581
2023 Q1	$18K	Hold	980	–	–	﹤0.01%	1396
2022 Q4	$13K	Sell	980 -456,610	-100%	-$6.99M	﹤0.01%	1392
2022 Q3	$8.75M	Buy	+457,590	New	+$8.34M	0.02%	262

Other funds holding CDMO

TCWM

Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bessemer Group's CDMO Position: Q1 2025 in Review

Bessemer Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 160 shares — an estimated $2K sold.

Bessemer Group first reported a position in CDMO in Q3 2022 and held it in 6 quarters. The position peaked at $8.75M in Q3 2022. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

Bessemer Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Bessemer Group sold 160 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $2K.
Bessemer Group first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
Bessemer Group's Avid Bioservices, Inc. Common Stock position peaked at $8.75M in Q3 2022.
2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Bessemer Group's 13F filing for Q1 2025, filed 23 Apr 2025.